Long-term stability of ranibizumab shown in DME patients
May 6th 2014In roughly 25% of patients, no further treatment was required to maintain mean visual acuity (VA) outcomes achieved at the exit of the RIDE/RISE 3-year core studies evaluating the efficacy of ranibizumab in patients with diabetic macular edema (DME), according to Allen Ho, MD.
Predictors for the number of AMD injections
May 4th 2014Retinal angiomatous proliferation (RAP) lesions, treatment with ranibizumab, the absence of subretinal fluid, and the absence of subretinal pigment epithelium fluid (RPE) were associated with fewer injections for neovascular age-related macular degeneration (AMD) among participants from the Comparison of AMD Treatments Trials (CATT), said Daniel F. Martin, MD.
The ongoing evolution in refractive surgery: Phakic IOLs
May 1st 2014Contemporary phakic IOLs are safe and effective for treating high ametropias. Further developments are expected to address some of the remaining needs, but the problem of complications due to interference with surrounding ocular tissues may never be overcome.
Role of phacotrabeculectomy shifting but not disappearing
May 1st 2014Based on unknown preoperative anatomic considerations, efficacy, and safety data, phacotrabeculectomy may be a better option than phacoemulsification alone or combined with a microincision glaucoma surgical procedure in eyes with advanced glaucoma needing cataract surgery and low IOP.
Why a new oral therapy for hepatitis C may be a game changer
May 1st 2014The looming promise of a well-tolerated and extremely effective oral agent to eradicate HCV infection is exciting, as it offers the possibility of eliminating this disease as a significant public health problem, as well as the albeit uncommon ophthalmic manifestations.
Challenge: Explain vision research to a child
May 1st 2014As a vital part of securing public support for vision research, the Association for Research in Vision and Ophthalmology (ARVO) posed a challenge to members of the eye and vision research community. Can you explain your research to a 12-year-old child in one or two sentences?
Study finds drug-eluting punctum plug safe, effective
May 1st 2014In a multicenter phase II study of cataract surgery patients, recipients of a dexamethasone-releasing punctum plug (Ocular Therapeutix) were significantly more likely than their vehicle-treated counterparts to be free of pain and anterior chamber cells at various postoperative follow-up visits.
Intravitreal antibiotic + steroid makes dropless cataract surgery possible
May 1st 2014A retrospective analysis including data from a consecutive series of 1575 eyes shows that intravitreal placement of triamcinolone/moxifloxacin during cataract surgery is a safe and effective method for preventing inflammation, endophthalmitis, and cystoid macular edema.